insulin aspart-fsan

FDA Drug Profile — Garzulys

insulin aspart-fsan is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Garzulys. Available dosage form: injection, solution.

Drug details

Generic Name
insulin aspart-fsan
Brand Names
Garzulys
Application Number
BLA761497
Sponsor
Meitheal Pharmaceuticals Inc.
NDC Codes
2
Dosage Forms
INJECTION, SOLUTION
Routes
INTRAVENOUS, SUBCUTANEOUS
Active Ingredients
INSULIN ASPART

Indications and Usage

1 INDICATIONS AND USAGE Garzulys™ is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. Garzulys is rapid acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus ( 1 ).

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.